Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi

The introduction of the nine-month short-treatment regimen (STR) has drastically improved outcomes of rifampicin-resistant tuberculosis (RR-TB) treatment. Adverse events (AE) commonly occur, including injectable-induced hearing loss. In Burundi we retrospectively assessed the frequency of adverse ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciza, François, Gils, Tinne, Sawadogo, Michel, Decroo, Tom, Roggi, Alberto, Piubello, Alberto, Ortuño-Gutiérrez, Nimer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356788/
https://www.ncbi.nlm.nih.gov/pubmed/32560052
http://dx.doi.org/10.3390/jcm9061873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356788/
https://www.ncbi.nlm.nih.gov/pubmed/32560052
http://dx.doi.org/10.3390/jcm9061873

Ejemplares similares